ARYx Therapeutics, Inc. Stock

ARYX

US0433871094

Biotechnology & Medical Research

Market Closed - OTC Markets 16:47:07 26/06/2023 +03			5-day change	1st Jan Change
0.001200 ^USD	+1,100.00%		+119,900.00%	+119,900.00%

1 week	+119,900.00%
Current month	+119,900.00%

Valuation : ARYx Therapeutics, Inc.

Market Cap	9.03M 7.79M 7.3M 6.66M 12.55M 863M 12.59M 86.6M 33.79M 436M 33.92M 33.18M 1.45B	P/E 2008	-1.76x	P/E 2009	-2.66x
Enterprise Value	11.41M 9.83M 9.22M 8.41M 15.85M 1.09B 15.9M 109M 42.66M 550M 42.82M 41.89M 1.82B	EV / Sales 2008	4,019,605x	EV / Sales 2009	-
Free-Float	100%	Yield 2008 *	-	Yield 2009	-

* Estimated data More valuation ratios

Press Releases : ARYx Therapeutics, Inc.

10/03/11	ARYX THER : ARYx Therapeutics Informed of Additional Delay by FDA and Begins Wind-Down of Operations	BU
24/12/10	ARYX THER : ARYx Therapeutics Clarifies Current Status of Operations	BU
21/12/10	ARYX THER : ARYx Therapeutics to Transfer to the NASDAQ Capital Market	BU
16/12/10	ARYX THER : ARYx Therapeutics Provides Update on Company Status	BU
15/11/10	ARYX THER : ARYx Therapeutics Reports Third Quarter Results	BU

More press releases

ARYx Therapeutics, Inc. is a United States-based pharmaceutical Company. The Company is developing a proprietary portfolio of patient-targeted, first-in-class monoclonal antibodies designed to treat seriously ill patients with difficult-to-treat diseases. It is engaged in retrometabolic drug design that focuses on the safety of oral therapies for chronic disease. The Companys clinical compounds include naronapride (ATI-7505) for gastrointestinal disorders; budiodarone (ATI-2042, for the treatment of atrial fibrillation; tecarfarin (ATI-5923) for the treatment of anticoagulation; and ATI-9242, for psychiatric disorders.

Employees

Sector

Biotechnology & Medical Research

More about the company

Stock Market
Stocks
ARYX Stock

As early as today, start finding the best investment opportunities!

3 years	0		0
5 years	0		0
10 years	0		0.05

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ARYX THERAPEUTICS, INC.	+1,100.00%	+119,900.00%	+119,900.00%	+119,900.00%	33
WUXI APPTEC CO., LTD.	-1.59%	-3.35%	+64.49%	+98.69%	69.54B
ARGENX SE	-1.34%	-0.75%	+48.56%	+90.63%	64.97B
BIONTECH SE	-8.37%	-12.43%	+0.14%	-15.42%	25.64B
INSMED INCORPORATED	-2.35%	-5.75%	-12.17%	+448.29%	25.89B
WUXI BIOLOGICS (CAYMAN) INC.	+0.30%	-0.69%	+63.18%	+11.93%	26.51B
PHARMAESSENTIA CORPORATION	-0.96%	+10.36%	+278.86%	+438.78%	20.22B
GENMAB A/S	-0.51%	+0.23%	+33.71%	-18.02%	19.98B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-1.91%	-4.37%	+13.33%	+531.29%	15.69B
EXELIXIS, INC.	-1.47%	+0.68%	+43.67%	+145.49%	13.49B
Average	+108.18%	-1.73%	+12,043.38%	+12,163.17%	28.19B
Weighted average by Cap.	-1.93%	-1.50%	+57.15%	+152.82%

	2008	2009
Net sales	19.72 17 15.94 14.55 27.4 1.89K 27.49 189.06 73.77 951.59 74.05 72.44 3.16K	-
Net income	-31.22M -26.9M -25.22M -23.02M -43.37M -2.98B -43.51M -299M -117M -1.51B -117M -115M -4.99B	-33.17M -28.58M -26.8M -24.46M -46.08M -3.17B -46.23M -318M -124M -1.6B -125M -122M -5.31B
Net Debt	-29.9 -25.77 -24.16 -22.06 -41.55 -2.86K -41.68 -286.65 -111.84 -1.44K -112.28 -109.84 -4.78K	2.37 2.04 1.92 1.75 3.29 226.61 3.3 22.73 8.87 114.39 8.9 8.71 379.3

ARYx Therapeutics, Inc. Stock

Stocks

ARYX

US0433871094

Biotechnology & Medical Research

Valuation : ARYx Therapeutics, Inc.

Press Releases : ARYx Therapeutics, Inc.

Quotes and Performance

Price Extremes

Bio Therapeutic Drugs

Financials

Company Profile

1 day	+1,100.00%
1 week	+119,900.00%
Current month	+119,900.00%
1 month	+119,900.00%
3 months	+119,900.00%
6 months	+119,900.00%
Current year	+119,900.00%